October 23, 2018
Join leaders in the Canadian cannabis industry for an in-depth look at the legal and regulatory landscape of medical and recreational cannabis. The Blakes Cannabis Summit will feature thought leaders from across the sector, along with Blakes lawyers, who will delve into the latest developments, potential challenges and opportunities that lie ahead for businesses. Topics and Panelists: Capital Markets…
October 18, 2018
The recent restructuring proceedings of Concordia International Corp. (Concordia) demonstrate that the arrangement provisions of the Canada Business Corporations Act (CBCA) remain as a powerful tool for balance sheet restructurings in Canada. These provisions allow a company to submit a plan of arrangement for creditor and court approval in order to achieve a balance sheet restructuring in a timely and…
July 18, 2017
What does “useful”, one of the basic requirements for the patentability of an invention, mean in Canadian patent law? On June 30, 2017, in AstraZeneca Canada Inc. v. Apotex Inc. (AstraZeneca), the Supreme Court of Canada (SCC) ruled that the threshold for utility is low — a mere scintilla will do. In fact, requiring anything more is not only overly…
April 10, 2017
The end of 2016 brought with it some good news for the defence in respect of pharmaceutical class actions, including a successful defence verdict in the first pharmaceutical product liability common issues trial in Canada. This article discusses key pharmaceutical class actions from 2016.